Clinical Trials Insight: 700014288
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2008
At a glance
- Drugs AR 709 (Primary)
- Indications Respiratory tract infections; Streptococcal infections
- Focus Pharmacokinetics
- Sponsors Arpida
- 01 Sep 2008 Status changed from active, no longer recruiting to completed as reported by an Arpida media release.
- 01 Sep 2008 Results published in March 2007, according to an Arpida media release.
- 29 Mar 2007 Interim results have been reported